Related Experiment Video
Updated: Jul 8, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression
Zi-Miao Liu1, Huei-Sheng Huang
1Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
Abstract:
Although arsenic is an infamous carcinogen, it has been effectively used to treat acute promyelocytic leukemia, and can induce cell cycle arrest or apoptosis in human solid tumors. Previously, we had demonstrated that opposing effects of ERK1/2 and JNK on p21 expression in response to arsenic trioxide (As(2)O(3)) are mediated through the Sp1 responsive elements of the p21 promoter in A431 cells. Presently, we demonstrate that Sp1, and c-Jun functionally cooperate to activate p21 promoter expression through Sp1 binding sites (-84/-64) by using DNA affinity binding, chromatin immunoprecipitation, and promoter assays. Surprisingly, As(2)O(3)-induced c-Jun(Ser63/73) phosphorylation can recruit TGIF/HDAC1 to the Sp1 binding sites and then suppress p21 promoter activation. We suggest that, after As(2)O(3 )treatment, the N-terminal domain of c-Jun phosphorylation by JNK recruits TGIF/HDAC1 to the Sp1 sites and then represses p21 expression. That is, TGIF is involved in As(2)O(3)-inhibited p21 expression, and then blocks the cell cycle arrest.
Insights
Arsenic trioxide (As(2)O(3)) treatment surprisingly represses p21 expression by recruiting TGIF/HDAC1 to Sp1 binding sites, inhibiting cell cycle arrest. This mechanism involves c-Jun phosphorylation by JNK, impacting solid tumor treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Arsenic trioxide (As(2)O(3)) exhibits anti-cancer properties by inducing cell cycle arrest and apoptosis.
- Previous studies identified opposing roles of ERK1/2 and JNK in regulating p21 expression via Sp1 in response to As(2)O(3).
Purpose of the Study:
- To elucidate the functional cooperation between Sp1 and c-Jun in activating the p21 promoter.
- To investigate the mechanism by which As(2)O(3) influences p21 expression through c-Jun phosphorylation and recruitment of co-factors.
Main Methods:
- DNA affinity binding assays
- Chromatin immunoprecipitation (ChIP)
- Promoter activity assays
- Western blotting for phosphorylated c-Jun
Main Results:
- Sp1 and c-Jun were shown to functionally cooperate in activating the p21 promoter at specific Sp1 binding sites (-84/-64).
- As(2)O(3)-induced phosphorylation of c-Jun at Ser63/73 led to the recruitment of TGIF/HDAC1 complex to the Sp1 binding sites.
- This recruitment resulted in the suppression of p21 promoter activation, thereby inhibiting cell cycle arrest.
Conclusions:
- TGIF/HDAC1 complex plays a critical role in As(2)O(3)-mediated repression of p21 expression.
- The findings reveal a novel mechanism where As(2)O(3) inhibits cell cycle arrest by suppressing p21 expression through a JNK-c-Jun-TGIF/HDAC1 pathway.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
TGF - β Signaling Pathway
Negative Regulator Molecules
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...